Michael Landsittel
2019
Compensation breakdown
| Non-Equity Incentive Plan | $125,580 |
|---|---|
| Option Awards | $1,025,090 |
| Salary | $345,000 |
| Stock Awards | $454,650 |
| Other | $8,400 |
| Total | $1,958,720 |
Landsittel received $1M in option awards, accounting for 52% of the total pay in 2019.
Landsittel also received $125.6K in non-equity incentive plan, $345K in salary, $454.7K in stock awards and $8.4K in other compensation.
Rankings
In 2019, Michael Landsittel's compensation ranked 6,043rd out of 13,971 executives tracked by ExecPay. In other words, Landsittel earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,043 out of 13,971 | 57th |
Division Manufacturing | 2,266 out of 5,701 | 60th |
Major group Chemicals And Allied Products | 818 out of 2,200 | 63rd |
Industry group Drugs | 691 out of 1,886 | 63rd |
Industry Pharmaceutical Preparations | 509 out of 1,398 | 64th |
Pay ratio
| Michael Landsittel's Pay | $1,958,720 |
|---|---|
| Median Employee's Pay | $360,897 |
| Pay Ratio | 5to 1 |
In 2019, the annual total compensation of Michael Landsittel was $1,958,720.
The annual total compensation of the median employee at Blueprint Medicines was $360,897.
The ratio of Michael Landsittel's pay to the pay of median employee was therefore 5 to one.
Landsittel's colleagues
We found four more compensation records of executives who worked with Michael Landsittel at Blueprint Medicines in 2019.